克林霉素是林可霉素类产品,抗菌活性较林可霉素强4～8倍。力派(Ｌｉｐａｉ)是克林霉素磷酸酯注射液。我院用力派治疗肺癌合并下呼吸道感染患者,取得较好效果,现总结如下。1　病例选择确诊为合并下呼吸道感染的肺癌患者30例,男22例,女8例,年龄36～72岁,平均54岁。其中肺鳞癌21例 Clindamycin is a product of lincomycin, and its antibacterial activity is 4 to 8 times stronger than that of lincomycin. Lipai is a clindamycin phosphate injection. Our hospital has used force to treat patients with lung cancer and lower respiratory tract infections and achieved better results. The results are summarized below. 1 Cases were diagnosed as 30 cases of lung cancer patients with lower respiratory tract infection. There were 22 males and 8 females, aged 36-72 years, with an average age of 54 years. Among them, 21 cases of squamous carcinoma